Drug Shortage Report for TEVA-TAMOXIFEN

Last updated on 2020-02-07 History
Report ID 92186
Drug Identification Number 00851973
Brand name TEVA-TAMOXIFEN
Common or Proper name TAMOXIFEN
Company Name TEVA CANADA LIMITED
Active Ingredient(s) TAMOXIFEN
Strength(s) 20MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100
ATC code L02BA
ATC description HORMONE ANTAGONISTS AND RELATED AGENTS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2019-08-22
Estimated end date 2020-03-15
Actual end date
Shortage status Actual shortage
Updated date 2020-02-07
Company comments We are allocating to the end of Feb to cover approx. 30% of market demand.
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v15 2020-02-07 French Compare
v14 2020-02-07 English Compare
v13 2020-02-07 French Compare
v12 2020-02-07 English Compare
v11 2020-01-17 French Compare
v10 2020-01-17 English Compare
v9 2019-11-18 French Compare
v8 2019-11-18 English Compare
v7 2019-09-26 French Compare
v6 2019-09-26 English Compare
v5 2019-09-12 French Compare
v4 2019-09-12 English Compare
v3 2019-08-23 English Compare
v2 2019-08-22 French Compare
v1 2019-08-22 English Compare